CRON News and Press, Cronos Group Inc. From 01/19/21

At first glance, Canada looks like a marijuana industry paradise given that the drug is fully legal throughout the country. So why do homegrown companies like Cronos (NASDAQ: CRON) continue to struggle there? In this video clip from Motley Fool Live , longtime Motley Fool co...

Canopy Growth trades at C$16B market cap and 40x EV/Sales despite reporting only C$135M revenue and negative C$86M EBITDA last quarter. The company has no near-term path to break-even EBITDA and has already burned through $3.5B of the $5.0B cash from Constellation. The stock has a...

Cannabis companies are starting to turn a profit and print positive EPS. Here are the few that are earning a profit. Many companies are close to turning a positive EPS. The industry itself is expected to expand some 100% in the next couple of years, and with economies of scale, th...

FN Media Group Presents Safehaven.com Market Commentary New York, NY – January 19, 2021 – One under-the-radar company looks to be an absolute game-changer for the healthcare industry. That’s because, despite “Big Pharma’s” massiv...

Altria is a regulatory capture play that sells addictive products. Its stock has recently performed poorly due to poor acquisition timing, regulatory worries, and changing sentiment. The original thesis of it having runway to raise prices is still intact. I think Alt...

Are These Marijuana Stocks Worth Your Time And Money? Now that the new year is here marijuana stocks in 2021 have been performing well in the market. Cannabis stocks like Trulieve Cannabis Corp. ( OTC:TCNNF ) and Curaleaf Holdings, Inc. ( OTC:CURLF ) both have reached ne...

Tilray shares gained 137% in 2021 so far but they are only up 13% since January 1, 2020, due to its weak performance in 2020. We think Tilray has more upside due to its strong business fundamentals (with Aphria) and its discounted valuation to Canopy and Cronos. The recent rally c...

Aurora shares cratered ~65% in 2020 but have gained ~30% in 2021 so far on hopes of U.S. legalization. The business began restructuring in 2020 by shedding non-cannabis assets and shutting down ~90% of its cultivation capacity. Aurora has $450M of cash which provides ample liquidi...

Cantor Fitzgerald raises the price target of Aphria Inc, ([[APHA]] +11.3%) to C$26.00 from C$15.25 with an Overweight rating noting that ‘other reasons were at play’ for shares to gain 20% despite what the analyst felt as ‘disappointing’ earnings results for Q3 FY2...

The cannabis stocks are rallying as Aphria (APHA) beat revenue and earnings for the second quarter of fiscal 2021 ahead of its merger with Tilray ([[TLRY]] +23.5%) scheduled for the second quarter of 2021.For the seventh quarter in succession, Aphria’s gross revenue for ...